Skip to Main Content

Dr. Lisa Cameron is an economist with over two decades of experience consulting to attorneys and companies involved in commercial litigation, regulatory proceedings, and other complex matters.

Her industry expertise includes pharmaceuticals, biologics, e-commerce, medical devices, telecommunications, software, consumer products, energy, electrical equipment, and transportation.

Dr. Cameron has broad experience in intellectual property, antitrust, regulatory policy, and transfer pricing matters and has analyzed damages, liability, and requests for injunctive relief. In patent disputes, she has testified on both commercial success and damages. She has also testified in matters involving competition and investment incentives before the Federal Energy Regulatory Commission and state public utility commissions.

Prior to joining Brattle, Dr. Cameron held senior positions at Cornerstone Research, Deloitte Financial Advisory Services, and Lexecon Inc. Prior to becoming a consultant, Dr. Cameron was a professor of economics in Carnegie Mellon University’s Graduate School of Business, where she taught courses in microeconomic theory, regulation, and antitrust policy.

Representative Engagements
Damages assessment in software patent infringement case
For a major software company, assessed damages associated with the company’s alleged infringement of a business methods patent that supported one of the software’s features. Empirically demonstrated that usage of the patented feature had been minimal and was not integral to the commercial success of the software package as a whole.
Analysis of liability and damages arising from alleged non-disclosure
Worked on behalf of a large multinational involved in a dispute over whether it had disclosed a regulatory pricing restriction when it sold its pharmaceuticals division. Quantified damages resulting from alleged non-disclosure. Also assessed the degree to which information on the pricing restriction had been captured by disclosures made during the acquisition process.
Liability issues in pharmaceutical patent cases
In numerous cases alleging that patents on a branded drug were invalid due to obviousness, analyzed the branded drugs’ commercial success. These analyses explained economic criteria for commercial success, evaluated the drugs’ success with respect to those criteria, and reviewed the strength of the nexus between the drug’s patented properties and its sales.
Conjoint analysis in Copyright Royalty Board proceeding
On behalf of SoundExchange, which collects fees from music streaming services for the performance of sound recordings, conducted a conjoint survey to estimate the value that consumers place on key attributes of music streaming services, such as their ability to select songs on demand. Based on this analysis, prepared testimony for a Copyright Royalty Board (CRB) proceeding to set sound recording performance fees paid by Pandora and similar music services for the years 2016-2020.
Product hopping case in pharmaceutical industry
On behalf of Warner Chilcott, a major pharmaceutical company accused of “product hopping,” supported multiple experts in their analysis of the competitive implications of this practice. Our reports and analyses showed that: (i) generic manufacturers can and do rely on a variety of mechanisms other than AB-rated substitution to sell their products and (ii) third party payors can and do drive utilization from branded drugs towards cheaper therapeutic substitutes and that these shifts take place even when AB-rated generic substitutes are not available. Case won on summary judgment.
Testimony

The University of Sydney et al v. ObjectiVision Pty Ltd. (No. NSD 385 of 2014). Report on Damages.

December 2017

Milwaukee Electric Tool Corporation et al v. Chervon North America, Inc. (Case No. 2-14-cv-01289-JPS). Report on Commercial Success.

July 2017

Brigham and Women’s Hospital, Inc. and Investors Bio-Tech, L.P. v. Perrigo Company and L. Perrigo Company (Civ. No. 13-cv-1164). Reports on Damages and Commercial Success April 2016, Deposition May 2016, Jury Trial December 2016.

December 2016
Before the Federal Energy Regulatory Commission and the Regulatory Commission of Alaska, BP Pipelines (Alaska) Inc., FERC Docket No. IS09-348, RCA Docket P-08-9
October 2010
Before the Regulatory Commission of Alaska, In the Matter of the Application of Amerada Hess Pipeline Corporation and Phillips Transportation Alaska, Inc., for the Transfer of a 1.5% Interest in the Trans Alaska Pipeline System Docket No. P-02-10
November 2002
Before the Regulatory Commission of Alaska, In the Matter of the Application of BP Pipelines (Alaska), Inc. and Phillips Transportation Alaska, Inc. for the Transfer of a 3.0845% Interest in the Trans Alaska Pipeline System Docket No. P-01-08
May 2001 and July 2001
Publications
Article
Calculating Reasonable Royalty Damages Using Conjoint Analysis
August 2017
Published in the American Intellectual Property Law Association (AIPLA) Quarterly Journal

The article reviews the economic framework behind the calculation of reasonable royalty damages and explain how to implement two key methods of computing these damages—referred to as the Market Share Method (“MSM”) and the Equilibrium Profit Method (“EPM”).

Article
Interview with Joshua Gans on Interoperability, Disruption, and Antitrust
April 2017
Published in Perspectives in Antitrust
Article
Computing Damages in Product Mislabeling Cases: Plaintiffs' Mistaken Approach in Briseno v. ConAgra
February 27, 2017
Published in Bloomberg Bureau of National Affairs (BNA)

An article about fundamental economic errors in approaches to damages in recent product mislabeling cases.

Publication
Article
An Empirical Approach To Reverse Payment Settlements
July 06, 2015
Published on Law360
Report
Brief of Antitrust Economists as Amici Curiae in Support of Defendants-Appellants
January 15, 2015
Lisa J. Cameron, Steven Herscovici, Henry G. Grabowski, Sheila Coombs Branyan, Kenneth G. Elzinga, Paul Greenberg, James W. Hughes, Anne Layne-Farrar, Kevin M. Murphy, Janusz A. Ordover, Ann E. Querns, Bradley N. Reiff, Jeremy A. Rist, John Rizzo, William H. Roberts, Edward A. Snyder, Bruce Stangle, Robert H. Topel, and Michael Wohlgenant
Prepared for the United States Court of Appeals for the Second Circuit
Article
The Role Of Conjoint Surveys In Reasonable Royalty Cases
October 16, 2013
Published in Law360
Presentation
Patent Damages: The Role of Conjoint Surveys
August 2013
Presented at the American Bar Association Annual Meeting, San Francisco
Article
The Impact of Digitization on Business Models in Copyright-Driven Industries: A Review of the Economic Issues
February 26, 2013
In The Impact of Copyright on Innovation in the Digital Age, edited by Stephen A. Merrill and William J. Raduchel, published by The National Academy of Sciences' Board on Science, Technology, and Economic Policy
Report
The Employment Impacts of Proposed Tariffs on Chinese Manufactured Photovoltaic Cells and Modules
January 30, 2012
Prepared for the Coalition for Affordable Solar Energy
Report
Preliminary Injunctions in Pharmaceutical Litigation: The Economics of Irreparable Harm
February 2011
Published by The Brattle Group, Inc.
Article
Regulation and the structure of the telecommunications industry
2006
Gregory M. Duncan and Lisa J. Cameron
In International Handbook on Economic Regulation, edited by Michael Crew and David Parker, and published by Edward Elgar Publishing, Inc.
Article
Transmission Investment: Obstacles to a Market Approach
March 2001
Published in The Electricity Journal
Article
Limiting Buyer Discretion: Effects on Price and Performance in Long-Term Contracts
March 2000
Published in The American Economic Review
Article
The Role of the ISO in U.S. Electricity Markets: A Comparison of California and PJM
April 1999
Lisa J. Cameron and Peter Cramton
Published in The Electricity Journal
Article
Using Auctions to Divest Generation Assets
December 1997
Lisa J. Cameron, Peter Cramton, and Robert Wilson
Published in The Electricity Journal
News & Events
May 29, 2018
Lisa Cameron to Participate in Knowledge Group Webinar on Reasonable Royalty Damages

Brattle Principal Lisa Cameron will participate in The Knowledge Group’s Webinar, “Reasonable Royalty Damages, Apportionment and Expert Opinions in Light of Exmark Case,” taking place May 28, 2018 from 3:00-4:30 pm (ET).

August 03, 2017
Brattle Economists and Academic Advisors Publish Article in AIPLA Quarterly on Using Conjoint Analysis to Calculate Reasonable Royalty Damages

Brattle economists Lisa Cameron and Jeremy Verlinda and Academic Advisors Greg Allenby and Peter Rossi have recently contributed the article “Calculating Reasonable Royalty Damages Using Conjoint Analysis” to the American Intellectual Property Law Association Quarterly Journal.

May 23, 2017
Brattle Economists Interview Joshua Gans on Interoperability and Disruption for the ABA’s Perspectives in Antitrust

In an interview published in the ABA's Perspectives in Antitrust, Brattle economists Michelle Cleary and Lisa Cameron discussed interoperability, disruption, and antitrust with Professor Joshua Gans.

March 21, 2017
Lisa Cameron to Present on The Knowledge Group’s Webinar on Reverse Payment Settlements

Brattle Principal Lisa Cameron will present during The Knowledge Group’s webinar, “Reverse Payment Settlements: Hot Topics in 2017,” taking place March 21, 2017 from 3-5 pm EST.

February 28, 2017
Brattle Economists and Academic Advisors Author Article for BNA on Damages in Product Mislabeling Cases

Brattle Principal Lisa Cameron, Academic Advisors Professor Greg Allenby and Professor Peter E. Rossi, and Brattle Senior Research Analyst Yikang Li recently co-authored an article for BNA about fundamental economic errors in approaches to damages in recent product mislabeling cases.

February 27, 2017
Computing Damages in Product Mislabeling Cases: Plaintiffs' Mistaken Approach in Briseno v. ConAgra

Brattle Principal Lisa Cameron, Academic Advisors Professor Greg Allenby and Professor Peter E. Rossi, and Brattle Senior Research Analyst Yikang Li recently co-authored an article for BNA about fundamental economic errors in approaches to damages in recent product mislabeling cases.

March 29, 2016
Lisa Cameron to Participate in Robins Kaplan Seminar on Legal and Economic Developments in the Biotech Industry

Brattle Principal Lisa Cameron will present at the upcoming Robins Kaplan LLP seminar, “Recent Legal & Economic Developments that Affect Your Biotech Business,” taking place March 29, 2016 in Boston, MA.

February 25, 2016
Brattle Economists Contribute to Amicus Brief in Effexor Pay-for-Delay Litigation

Brattle Principals Steven Herscovici and Lisa Cameron and Academic Advisor Professor Joshua Gans recently assisted in preparing an amicus brief in support of defendants-appellees Wyeth LLC and Teva Pharmaceutical Industries Ltd in In re: Effexor XR Antitrust.

February 18, 2016
Lisa Cameron to Discuss “Footprint” Approach in Reasonable Royalty Damages at CLE Webinar

Brattle Principal Lisa Cameron will participate in an upcoming CLE webinar hosted by The Knowledge Group, “The Rise of the ‘Footprint’ Approach in Reasonable Royalty Damages: What’s New in 2016,” taking place on February 18, 2016 from 3:00-5:00pm EST.

August 31, 2015
Brattle Economists Sign Amicus Brief in Support of Defendants in Loestrin 24 FE Antitrust Case

Brattle Principals Lisa Cameron and Steven Herscovici recently assisted in preparing an amicus brief in support of defendants-appellants Warner Chilcott Company, LLC in In Re: Loestrin 24 FE Antitrust Litigation, an antitrust case that is currently before the United States Court of Appeals for the First Circuit.

July 07, 2015
Lisa Cameron and Joshua Gans Author Law360 Article on a New Model for Evaluating Reverse Payment Settlements

Brattle principal Dr. Lisa Cameron and academic advisor Professor Joshua Gans have co-authored an article for Law360 on how to quantify a branded pharmaceutical company’s beliefs about patent strength and expected patent life in reverse payment settlement cases.

May 29, 2015
Brattle Client Warner Chilcott Granted Summary Judgment in Pharmaceutical Antitrust Case

In a closely-watched pharmaceutical antitrust case, Brattle client Warner Chilcott prevailed in a motion for summary judgment against Mylan Pharmaceuticals. Mylan, which produced a generic version of Warner Chilcott’s branded acne medication Doryx, alleged that Warner Chilcott had acted anticompetitively by product hopping. A Brattle team led by principals Steve Herscovici and Lisa Cameron worked closely with attorneys from White & Case in providing analytical support for four different experts.

January 16, 2015
Brattle Economists Sign Amicus Brief in Support of Defendants Actavis PLC in Pharmaceuticals Antitrust Case

Brattle economists Lisa Cameron and Steven Herscovici recently assisted in preparing an amici curiae brief in support of the defendants-appellants Actavis PLC and its subsidiary, Forest Laboratories LLC, in an antitrust case in the United States Court of Appeals for the Second Circuit.

October 15, 2014
Andrew Abere and Lisa Cameron to Present to NYSBA Antitrust Section Executive Committee and the NYC Bar Association’s Antitrust and Trade Regulation Committee

Andrew Abere and Lisa Cameron have been selected to present at an upcoming meeting of the New York State Bar Association’s Antitrust Section Executive Committee and the New York City Bar Association’s Antitrust and Trade Regulation Committee. The event will take place on October 15, 2014 at Shearman & Sterling LLP in New York, NY.

September 18, 2014
Lisa Cameron to Present at Law Seminars International Conference on Calculating & Proving Patent Damages

Brattle principal Lisa Cameron has been selected to present at the Law Seminars International (LSI) conference on Calculating & Proving Patent Damages: Strategic Issues for Proving and Refuting Damages Claims.